Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.

Saved in:
Bibliographic Details
Title: Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.
Authors: Scafetta R; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Troiano R; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Gullotta C; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Guarino A; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Fiore C; Medical Oncology Unit, Santa Rosa Hospital, Department of Oncology and Hematology, Strada Sammartinese snc, Viterbo 01100, Italy., Sisca L; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Speziale E; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Donato M; Division of Medical Oncology, 'G.Martino' University Hospital, Via Consolare Valeria 1, Messina 98124, Italy., Foderaro S; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Roma 00128, Italy., Venuti F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Vilardi FA; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Ricozzi V; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Roma 00128, Italy., Iuliani M; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy. Electronic address: m.iuliani@policlinicocampus.it., Simonetti S; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Cavaliere S; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Cortellini A; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Roma 00128, Italy., Cesa A; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy., Botticelli A; Department of Radiological, Oncological and Pathological Science, 'Sapienza' University of Rome, Rome, Italy., Scagnoli S; Department of Radiological, Oncological and Pathological Science, 'Sapienza' University of Rome, Rome, Italy., Pisegna S; Department of Experimental Medicine Sapienza University, Rome, Italy; Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Via Di Grottaross, Rome 1035-1039, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy., Pedersini R; Medical Oncology Department, ASST Spedali Civili of Brescia, Brescia, Italy., Sposetti C; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy; Dana-Farber/Partners CancerCare, Boston, MA, USA; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tiberi E; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., D'Auria G; Department of Medical Oncology, Medical Oncology Unit, Sandro Pertini Hospital, Rome, Italy., Vergati M; Department of Medical Oncology, Medical Oncology Unit, Sandro Pertini Hospital, Rome, Italy., Mazzotta M; Department of Medical Oncology, Medical Oncology Unit, Sandro Pertini Hospital, Rome, Italy., Caputo R; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Verrazzo A; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Garrone O; Medical Oncology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Domati F; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Piombino C; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Lisa FSD; UOSD Sperimentazioni di fase IV - IRCCS Istituto Nazionale Tumori Regina Elena, Via Elio Chianesi 53, Roma 00144, Italy., Filomeno L; UOSD Sperimentazioni di fase IV - IRCCS Istituto Nazionale Tumori Regina Elena, Via Elio Chianesi 53, Roma 00144, Italy., Arcuri T; UOSD Sperimentazioni di fase IV - IRCCS Istituto Nazionale Tumori Regina Elena, Via Elio Chianesi 53, Roma 00144, Italy., Puce F; Medical Oncology Unit, ICS Maugeri IRCCS, Pavia, Italy., Riva F; Department of Clinical and Molecular Medicine, 'La Sapienza' University of Rome, Policlinico Umberto I, Viale Regina Elena 324, Rome 00161, Italy., Palleschi M; Medical Oncology, Breast & GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Sirico M; Medical Oncology, Breast & GYN Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Piras M; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy., Stucci LS; Interdisciplinary Department of Medicine, University of Bari 'A. Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy., Lisi D; Medical Oncology Unit, Santa Chiara Hospital, APSS Trento, Italy., Orsaria P; Department of Breast Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Grasso A; Department of Breast Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Ippolito E; Department of Radiation Oncology (Medicine and Surgery), Università Campus Bio-Medico di Roma, Rome, Italy; Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Ramella S; Department of Radiation Oncology (Medicine and Surgery), Università Campus Bio-Medico di Roma, Rome, Italy; Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Visani L; Radiation Oncology Unit & Breast Unit, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy., Livi L; Radiation Oncology Unit & Breast Unit, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy., Gori S; Medical Oncology, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella (VR), Italy., Rossi L; UOC of Oncology - ASL Latina - Distretto 1, University of Rome 'Sapienza', Formia, Italy., Meattini I; Radiation Oncology Unit & Breast Unit, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy; Department of Radiation Oncology (MAASTRO), GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Tagliaferri B; Medical Oncology Unit, ICS Maugeri IRCCS, Pavia, Italy., Caffo O; Medical Oncology Unit, Santa Chiara Hospital, APSS Trento, Italy; Center of Medical Science - University of Trento, Italy., Bonomo MV; Medical Oncology Unit, Policlinico Universitario Tor Vergata, Rome, Italy., Portarena I; Medical Oncology Unit, Policlinico Universitario Tor Vergata, Rome, Italy., Irelli A; Medical Oncology Unit, Department of Oncology, 'Giuseppe Mazzini' Hospital, AUSL 04 Teramo, Teramo 64100, Italy., Cretella E; Medical Oncology Unit, Ospedale di Bolzano, Bolzano, Italy., Porta C; Interdisciplinary Department of Medicine, University of Bari 'A. Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico di Bari, Bari, Italy., Bianchini G; Department of Medical Oncology, IRCCS San Raffaele Scientific Institute, Milan, Italy; Università Vita-Salute San Raffaele, Milano, Italy., Fabbri MA; Medical Oncology Unit, Santa Rosa Hospital, Department of Oncology and Hematology, Strada Sammartinese snc, Viterbo 01100, Italy., Giorgi U; Department of Experimental Medicine, University of Salento, Lecce, Italy., Vici P; UOSD Sperimentazioni di fase IV - IRCCS Istituto Nazionale Tumori Regina Elena, Via Elio Chianesi 53, Roma 00144, Italy., Toss A; Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Italy., Ruatta F; Medical Oncology Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan 20122, Italy., Laurentiis M; Department of Breast and Thoracic Oncology, Division of Breast Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Pascale, Naples, Italy., Villa F; Medical Oncology, Oncology Department ASST Lecco, Lecco 23900, Italy., Berardi R; Department of Medical Oncology, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Minelli M; UOC Oncologia Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy., Altomare V; Department of Breast Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Vernieri C; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy; European Institute of Oncology, IRCCS, Milano, Italy., Chirco A; ASST Papa Giovanni XXIII-SC Oncologia, Bergamo 24127, Italy., D'Alessandro S; ASST Papa Giovanni XXIII-SC Oncologia, Bergamo 24127, Italy., Vincenzi B; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Roma 00128, Italy., Tonini G; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Roma 00128, Italy., Santini D; Dip. Scienze e Biotecnologie Medico-chirurgiche, Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy., Pantano F; Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, Roma 00128, Italy; Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, Roma 00128, Italy.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 15; Vol. 239, pp. 116703. Date of Electronic Publication: 2026 Mar 27.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0852
DOI:10.1016/j.ejca.2026.116703